Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF)
$ 28.6 0 (0%) Market Cap: 44.77 Bil Enterprise Value: 71.99 Bil PE Ratio: 23.21 PB Ratio: 0.98 GF Score: 78/100

Q2 2025 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Oct 31, 2024 / 10:00AM GMT
Release Date Price: $27 (+1.16%)

Oct 31, 2024 / 10:00AM GMT
Presentation
Oct 31, 2024 / 10:00AM GMT

=====================
Corporate Participants
=====================
* Christopher O'Reilly
Takeda Pharmaceutical Co Ltd - Global Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Giles Platford
Takeda International Uk Branch - Director

=====================
Conference Call Participants
=====================
* Stephen Barker
Jefferies - Analyst
* Michael Nedelcovych
TD Cowen - Analyst
* Matsubara San
Nomura Securities Co. - Analyst
* Tony Ren
Macquarie Research - Analyst
* Miki Sogi
Bernstein - Analyst
* Editor

=====================
Christopher O'Reilly Takeda

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot